Terminated NA INTERVENTIONAL NCT00134875

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: Dec 31, 2000 Primary completion: Dec 31, 2002 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute of Allergy and Infectious Diseases (NIAID)

See all terminations from National Institute of Allergy and Infectious Diseases (NIAID)

Other Opioid-Related Disorders trials with similar outcome

Browse all Opioid-Related Disorders trials

A NA clinical study on Opioid-Related Disorders, this trial is terminated or withdrawn. The trial is conducted by National Institute of Allergy and Infectious Diseases (NIAID) and has accumulated 6 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Dec 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States